Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ocuphire Pharma, Inc. (OCUP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9000-0.1200 (-5.94%)
At close: 04:00PM EDT
2.0400 +0.14 (+7.37%)
After hours: 06:06PM EDT
Advertisement
Sign in to post a message.
  • G
    Gordon Gekko
    I have invested in many pharmaceutical companies with new drugs and I can say this one is the best one to make lots of money in as all phases of the new drugs are showing they will be Approved and the company will make Lots of Money.
  • M
    Morten
    They have a little presentation in Chinatown soon. Better than nothing https://biotochina.org/agenda/
  • G
    Garry
    At 1.90 a share, and all the trials going on w/ different products and seemingly good results so far, I HAVE to take a flier on this stock. Can't pass for this price.
    Bullish
  • N
    Neil
    just loaded it at 194 here is where you get it folks been waiting for this 👁️🏆
  • M
    Mark
    Low Float + low volume lately + good news + Premarket = SP to shoot up high. With this stock the opposite happens. LOL
  • M
    Muli
    The FDA-agreed primary endpoint was met, with a statistically significant greater percentage of Nyxol-treated subjects having gained 15 or more letters of mesopic low contrast distance visual acuity (mLCVA) at Day 8, compared to placebo (13% vs 3%; p<0.05)

    Key secondary efficacy endpoints were also met with statistical significance:

    The effect of Nyxol increased at Day 15, with 21% of subjects gaining 15 or more letters of mLCVA compared to 3% placebo (p<0.01)

    Nyxol significantly increased the percentage of subjects gaining 10 or more letters of mLCVA at both Day 8 with 41% vs. 22% placebo (p<0.05) and at Day 15 with 44% vs. 23% (p<0.05)
  • G
    Gordon Gekko
    This is a solid $20.00 stock once the FDA approval is given which is a no brainer as it’s approved far worse medications then this based on the phase 3 Results.
    Time To Buy Is Now
  • C
    Corn
    Who is buying?
  • N
    Neil
    sellers gone cleaned out now the accumulation begins along with the presentations in May 👁️
  • b
    brian
    295,000 shares traded in pre-market. Shot up to $2.50 and now dropped down to $1.94. That’s good news in bio Pharma for you
  • T
    TheKid69
    Wouldn’t be surprised if we close above $3 today or tomorrow
  • M
    Martin
    How long does market pause need to be. Coming up for 30 minutes, 25 after the news!!
  • i
    itssofine2
    Ouch!
  • b
    brian
    In reading the report the news is all good. This will soak into the market and the price will rise off of this press release. If can clear the way for more cash I’m inclined to buy more.
    The price going down this morning is people are just conditioned to sell on the news no matter what the news is. It will reverse.
  • N
    Neil
    got to wait for earnings any day now.... as far as the stock price it could go either way 👁️
  • G
    GS
    Curious, if Nyxol is approved... is there any money in this?
  • t
    trashedback
    .35 loss............
    Bullish
  • N
    NORBERTO RIVERA
    Geez, good news and its down. Ridiculous
    Bullish
  • N
    Neil
    bingo 265 area to buy... kudos to corn might go a bit lower who knows 👁️
  • C
    Ciaran
    Why are we down 20%
Advertisement
Advertisement